T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas - PubMed (original) (raw)
Comparative Study
T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas
M A Lowes et al. J Invest Dermatol. 1997 Jun.
Free article
Abstract
Spontaneous tumor regression, which is observed clinically and histologically in some primary melanomas, occurs in the absence of any effective therapy. It is probably immunologically mediated, because regressing melanomas are infiltrated with larger numbers of activated T cells, primarily CD4+, than nonregressing melanomas. To investigate the hypothesis that spontaneous regression of melanomas is caused by T-cell cytokine production, cytokine mRNA expression in 20 primary melanomas was examined using a noncompetitive, quantitative reverse-transcriptase polymerase chain reaction method. DNA standards were used to generate known numbers of molecules in each sample. Results were standardized to the internal control, glyceraldehyde-3-phosphate dehydrogenase. mRNA for CD35, lymphotoxin (TNF-beta), and IL-2 were significantly elevated in the ten regressing melanomas compared to the ten nonregressing melanomas. IFN-gamma mRNA was also elevated in regressing melanomas but failed to reach statistical significance. The Th2 cytokines IL-10 and IL-13 did not show differences in the regressing melanomas compared to nonregressing melanomas; neither did the pro-inflammatory cytokines IL-1alpha, IL-1beta, IL-6, IL-8, and TNF-alpha, nor the growth factors, bFGF and TGF-beta or GM-CSF. This study shows an association between Th1 cytokines and spontaneously regressing melanomas. Although we have not shown that these cytokines cause regression, these findings support our hypothesis that activated CD4+ T cells may mediate melanoma regression by secretion of Th1 cytokines.
Similar articles
- Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
Saed G, Fivenson DP, Naidu Y, Nickoloff BJ. Saed G, et al. J Invest Dermatol. 1994 Jul;103(1):29-33. doi: 10.1111/1523-1747.ep12388985. J Invest Dermatol. 1994. PMID: 8027577 - Cytokine profiles in spontaneously regressing basal cell carcinomas.
Wong DA, Bishop GA, Lowes MA, Cooke B, Barnetson RS, Halliday GM. Wong DA, et al. Br J Dermatol. 2000 Jul;143(1):91-8. doi: 10.1046/j.1365-2133.2000.03596.x. Br J Dermatol. 2000. PMID: 10886141 - Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype.
Gattorno M, Facchetti P, Ghiotto F, Vignola S, Buoncompagni A, Prigione I, Picco P, Pistoia V. Gattorno M, et al. Clin Exp Immunol. 1997 Jul;109(1):4-11. doi: 10.1046/j.1365-2249.1997.4331330.x. Clin Exp Immunol. 1997. PMID: 9218817 Free PMC article. - [Cytokines: current status and prospects in the treatment of skin tumors].
Nashan D, Luger TA. Nashan D, et al. Hautarzt. 2001 Aug;52(8):691-6. doi: 10.1007/s001050170082. Hautarzt. 2001. PMID: 11544938 Review. German. - Neurotropic melanoma with prominent melanization.
Barnhill RL, Bolognia JL. Barnhill RL, et al. J Cutan Pathol. 1995 Oct;22(5):450-9. doi: 10.1111/j.1600-0560.1995.tb00762.x. J Cutan Pathol. 1995. PMID: 8594079 Review.
Cited by
- Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist's Perspective on Current Knowledge.
Martínez-Vila C, González-Navarro EA, Teixido C, Martin R, Aya F, Juan M, Arance A. Martínez-Vila C, et al. Int J Mol Sci. 2024 Aug 31;25(17):9506. doi: 10.3390/ijms25179506. Int J Mol Sci. 2024. PMID: 39273452 Free PMC article. Review. - [Diagnostics and treatment of secondary malignancies of the parotid gland-An overview].
Mayer M, Nachtsheim L, Arolt C, Quaas A, Prinz J, Grosheva M, Klußmann JP, Wolber P. Mayer M, et al. HNO. 2023 Apr;71(4):223-231. doi: 10.1007/s00106-022-01178-6. Epub 2022 May 17. HNO. 2023. PMID: 35579673 Review. German. - Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma.
Maibach F, Sadozai H, Seyed Jafari SM, Hunger RE, Schenk M. Maibach F, et al. Front Immunol. 2020 Sep 10;11:2105. doi: 10.3389/fimmu.2020.02105. eCollection 2020. Front Immunol. 2020. PMID: 33013886 Free PMC article. Review. - Targeting macrophage anti-tumor activity to suppress melanoma progression.
Wang H, Zhang L, Yang L, Liu C, Zhang Q, Zhang L. Wang H, et al. Oncotarget. 2017 Mar 14;8(11):18486-18496. doi: 10.18632/oncotarget.14474. Oncotarget. 2017. PMID: 28060744 Free PMC article. Review. - SOCE and cancer: Recent progress and new perspectives.
Xie J, Pan H, Yao J, Zhou Y, Han W. Xie J, et al. Int J Cancer. 2016 May 1;138(9):2067-77. doi: 10.1002/ijc.29840. Epub 2015 Sep 29. Int J Cancer. 2016. PMID: 26355642 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials